Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

First-line systemic treatment patterns and outcomes in lung cancer patients with malignant pleural effusion: a retrospective multicenter study

Background Malignant pleural effusion (MPE) is a frequent complication of advanced lung cancer with poor prognosis. The optimal first-line systemic treatment for these patients remains unclear. This study aimed to evaluate first-line systemic treatment patterns and outcomes in lung cancer patients with MPE. Methods Thi...

Yuan-Yuan Zhang, Ran Wang, Yi Xiang et al. · 0 citations
Clinical trial Open access Aug 2026

Mefatinib versus gefitinib as a first-line treatment for EGFR-mutated non-small cell lung cancer: a randomized, double-blind, multicenter phase III study

Mefatinib demonstrated superior efficacy to gefitinib with a similar tolerability profile in the first-line treatment of EGFR-mutated advanced NSCLC with common and uncommon EGFR-activating mutations.

Jia Yu, Anwen Xiong, Qi-Ming Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.